Am I interpreting this correctly
Local residents in Palm City, Jensen Beach, Hobe Sound, and Port St
Research on IV versus oral NAD+ precursors shows similar blood NAD+ increases
After obtaining favorable results in the investigator-initiated Phase III trial JETALS, and following consultation with Tokushima University, Eisai submitted a new drug application for the treatment of ALS in Japan in January 2024, leading to its approval in September, 2024 and leading to the launch today
When using over-the-counter homeopathic complexes, simply follow the product guidelines
References 1 AbajoZ.JimenezA.Domingo-EchaburuS.ValcrcelY.SeguraY.OriveG.et al (2023)